BCIQ Profiles

Company Profile Report

July 16 Quick Takes: Biotech stocks fare worse than others in STAR tumble; plus BioAtla, Exalys, Virometix, Biose, Spirea

Biotechs on STAR suffer amid broader sell-off
As concerns about the COVID-19 outbreak and a mixed recovery outlook rattled stocks traded in Shanghai, biotech stocks on the STAR exchange generally fared worse than the Shanghai Composite Index’s 4.5% downturn

Read the full 381 word article

How to gain access

Continue reading with a
two-week free trial.